Efficacy and Safety Study of Cardunilizumab in Soft Tissue Sarcoma
Clinical trial NCT06114173 · UNKNOWN
Trial details
- NCT number
- NCT06114173
- Sponsor
- Xiangya Hospital of Central South University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2023-06-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.